Literature DB >> 20510460

Expression of anti-cardiolipin antibodies and inflammatory associated factors in patients with schizophrenia.

Sheng-Huang Chang1, Szu-Yi Chiang, Chun-Ching Chiu, Chun-Chou Tsai, Huei-Huang Tsai, Chih-Yang Huang, Tsai-Ching Hsu, Bor-Show Tzang.   

Abstract

Numerous studies have implicated a connection between schizophrenia and autoimmune disorders. However, the precise relationship and underlying mechanism are still obscure. To further identify the association between autoimmune disorders and schizophrenia, the mRNA expressions of various cytokines and Toll-like receptors (TLRs) in monocytes are examined by using RT-PCR. Additionally, ELISA and zymography were performed to determine the anti-cardiolipin antibody (aCL) and MMP9 activity in serum form schizophrenic patients. Notably, significantly increased interleukin (IL)-6 and IL-10 mRNA were observed in schizophrenic patients, whereas significant reductions of TLR-3 and TLR-5 mRNA were detected. Moreover, significantly increased levels of aCL antibody and a higher frequency of positive-MMP9 activity were detected in serum from patients with schizophrenia. Meanwhile, no significant association was found between each of the medications and aCL activity. These findings demonstrated autoimmune-related phenomena in schizophrenic patients and further suggested a connection between schizophrenia and autoimmune disorders.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510460     DOI: 10.1016/j.psychres.2010.04.049

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  19 in total

Review 1.  Matrix Metalloproteinase-9 as a Novel Player in Synaptic Plasticity and Schizophrenia.

Authors:  Katarzyna Lepeta; Leszek Kaczmarek
Journal:  Schizophr Bull       Date:  2015-04-02       Impact factor: 9.306

2.  Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Meredith Halling; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Didier Dupont; Faith B Dickerson; Robert H Yolken
Journal:  Neurobiol Dis       Date:  2012-07-16       Impact factor: 5.996

3.  CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4.

Authors:  O M Ogundele; C C Lee
Journal:  Brain Res Bull       Date:  2017-11-11       Impact factor: 4.077

4.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

Review 5.  Anti-phospholipid syndrome associated with schizophrenia description of five patients and review of the literature.

Authors:  Pikman Regina; Rotman Pnina; Aiman Natur; Levy Yair
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

6.  Schizophrenia-derived hiPSC brain microvascular endothelial-like cells show impairments in angiogenesis and blood-brain barrier function.

Authors:  Bárbara S Casas; Gabriela Vitória; Catalina P Prieto; Mariana Casas; Carlos Chacón; Markus Uhrig; Fernando Ezquer; Marcelo Ezquer; Stevens K Rehen; Verónica Palma
Journal:  Mol Psychiatry       Date:  2022-06-15       Impact factor: 15.992

7.  Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Bintou Gassama; Dale Sebastian; Peter Buckley; Andrew Mellor
Journal:  Biol Psychiatry       Date:  2012-10-11       Impact factor: 13.382

8.  The association of matrix metalloproteinase 9 (MMP9) with hippocampal volume in schizophrenia: a preliminary MRI study.

Authors:  Johanna Seitz-Holland; Magdalena Seethaler; Nikos Makris; Jarrett Rushmore; Kang-Ik K Cho; Elizabeth Rizzoni; Mark Vangel; Olcay Senay Sahin; Carina Heller; Ofer Pasternak; Filip Szczepankiewicz; Carl-Fredrik Westin; Jan Lošák; Libor Ustohal; Josef Tomandl; Lubomír Vojtíšek; Petr Kudlička; Martin Jáni; T Wilson Woo; Tomáš Kašpárek; Zora Kikinis; Marek Kubicki
Journal:  Neuropsychopharmacology       Date:  2021-04-08       Impact factor: 7.853

9.  MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study).

Authors:  Dominik Strzelecki; Olga Kałużyńska; Justyna Szyburska; Adam Wysokiński
Journal:  Int J Mol Sci       Date:  2016-07-09       Impact factor: 5.923

10.  Association between toll-like receptor 4 expression and symptoms of major depressive disorder.

Authors:  Ming-Kung Wu; Tiao-Lai Huang; Kai-Wei Huang; Ya-Ling Huang; Yi-Yung Hung
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-30       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.